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Recently, the pharmaceutical industry is increasingly focusing on early drug development which comes with 
increasing constraints to accelerate process development, reduce costs and demonstrate a deep understanding 
cell culture processes. However, cellular metabolism is very complex and by far not fully understood. Cells can 
be cultivated in various types of bioreactors applying sophisticated feeding strategies mostly based on 
experience and series of experiments. Modern systems biology promises modeling of such processes on the 
basis of a system-wide understanding of cellular processes but is still unable to deliver predictive models in due 
time at reasonable cost. Practically applicable, predictive models are highly demanded in industry for the 
purpose of process optimization and control. To this end, we developed a systematic methodology for metabolic 
and cell growth modeling that is directly applicable in an industrial environment. We demonstrate that the 
models developed are able to predict a wide range of new experimental cell culture conditions. 
We applied the metabolic steady state concept and used a 
segmented linear model to predict cell metabolism (Fig. 1). 
The external metabolite rates are expressed as a linear 
function of the specific growth rate with various breakpoints 
associated to each metabolic shifts [1]. To predict the cell 
growth, an extended Monod-type model with inhibitory 
characteristics and varying maximum specific growth rate 
was developed. The final mAb titer can be predicted even if 
the cells are starved in some essential metabolites (Fig. 2). 
The cell growth model prediction was compared to the 
experimental one were two distinct essential metabolites 
were varied. The prediction was accurate. It was further 
possible to test various feeding strategies and to identify 
optimal experimental conditions. The cell growth model 
combined with a linear piecewise regression model of 
cellular metabolism allows us to get an in silico prediction 
of the impact of untested feeding strategies on cell culture 
performance.  
The models developed are believed to identify the essence 
of the biological processes and model parameters can be 
identified reliably. A complete metabolic network model is 
not required which makes the models more easily 
accessible. To the best of our knowledge, this is the first 
study that presents a simple linear model structure to 
describe mAb production but also amino acid, glucose, 
lactate and ammonium metabolism directly applicable for 
scale-up prediction. 
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Figure 2 – Comparison of experimental 
with predicted mAb titers 
Figure 1 – Phase identification and metabolic 
fluxes in different phases 
